Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 249,035 | 268,444 | 170,491 | 193,731 | 131,500 |
| Marketable Securities | 58,277 | 69,385 | 90,099 | 135,688 | 139,069 |
| Receivables | 181,180 | 177,948 | 174,420 | 173,085 | 211,746 |
| Inventories | 315,788 | 278,491 | 254,990 | 252,325 | 247,299 |
| Income taxes - deferred | 59,603 | 48,837 | 36,787 | 56,703 | 48,781 |
| Other current assets | 11,319 | 27,085 | 39,120 | 45,496 | 23,432 |
| TOTAL | $899,389 | $914,910 | $799,467 | $889,738 | $844,040 |
| Non-Current Assets | |||||
| PPE Net | 273,478 | 258,720 | 243,011 | 234,911 | 224,733 |
| Investments And Advances | 95,437 | 84,458 | 107,946 | 113,086 | 88,339 |
| Intangibles | 1,346,064 | 1,311,600 | 1,325,834 | 1,268,924 | 1,278,189 |
| Other Non-Current Assets | 21,675 | 21,675 | 21,675 | 21,675 | 102,423 |
| TOTAL | $1,736,654 | $1,676,453 | $1,698,466 | $1,638,596 | $1,693,684 |
| Total Assets | $2,636,043 | $2,591,363 | $2,497,933 | $2,528,334 | $2,537,724 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 79,392 | 76,103 | 56,102 | 68,102 | 64,102 |
| Accounts payable and accrued liabilities | 172,541 | 166,713 | 153,035 | 159,809 | 168,973 |
| Other current liabilities | 2,728 | 5,288 | 9,548 | 6,448 | 1,708 |
| TOTAL | $362,607 | $337,444 | $272,611 | $245,125 | $272,467 |
| Non-Current Liabilities | |||||
| Long Term Debt | 355,656 | 374,786 | 395,929 | 415,703 | 435,549 |
| aiOther Non-Current Liabilities | 5,962 | 6,212 | 6,381 | 9,311 | 10,637 |
| TOTAL | $513,075 | $527,420 | $548,630 | $611,159 | $641,654 |
| Total Liabilities | $875,682 | $864,864 | $821,241 | $856,284 | $914,121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,873 | 106,847 | 106,497 | 106,482 | 106,468 |
| Common Shares | 353 | 352 | 351 | 351 | 351 |
| Retained earnings | 955,752 | 915,095 | 855,139 | 823,054 | 776,761 |
| Other shareholders' equity | 7,474 | 17,295 | 29,933 | 57,903 | 56,866 |
| TOTAL | $1,760,361 | $1,726,499 | $1,676,692 | $1,672,050 | $1,623,603 |
| Total Liabilities And Equity | $2,636,043 | $2,591,363 | $2,497,933 | $2,528,334 | $2,537,724 |